002675 东诚药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.7744.4313.9724.4046.720
总资产报酬率 ROA (%)0.3632.1912.1992.5803.882
投入资产回报率 ROIC (%)0.4742.8242.7443.1704.764

边际利润分析
销售毛利率 (%)53.13250.96647.14044.86742.942
营业利润率 (%)7.7577.7577.69610.43012.511
息税前利润/营业总收入 (%)14.47513.07710.32911.25212.608
净利润/营业总收入 (%)5.5675.6344.9307.7619.847

收益指标分析
经营活动净收益/利润总额(%)101.399103.752100.357133.174123.056
价值变动净收益/利润总额(%)3.407-7.508-5.895-8.340-8.800
营业外收支净额/利润总额(%)-0.369-0.566-0.777-1.299-0.600

偿债能力分析
流动比率 (X)1.7071.6411.4641.2691.334
速动比率 (X)1.3841.3161.0950.8060.884
资产负债率 (%)41.12240.76537.79233.24235.400
带息债务/全部投入资本 (%)13.10012.26316.55420.06324.577
股东权益/带息债务 (%)462.000503.857397.083361.642290.453
股东权益/负债合计 (%)113.559115.691137.302177.740164.050
利息保障倍数 (X)2.1452.4383.83711.77873.434

营运能力分析
应收账款周转天数 (天)142.460123.217105.54989.56286.318
存货周转天数 (天)157.392157.867183.983197.538178.786